67 related articles for article (PubMed ID: 1913674)
1. Glucocorticoid insensitivity of P1798 lymphoma cells is associated with production of a factor that attenuates the lytic response.
Thompson EA
Cancer Res; 1991 Oct; 51(20):5551-6. PubMed ID: 1913674
[TBL] [Abstract][Full Text] [Related]
2. Insensitivity to the cytolytic effects of glucocorticoids in vivo is associated with a novel "slow death" phenotype.
Thompson EA
Cancer Res; 1991 Oct; 51(20):5544-50. PubMed ID: 1913673
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid inhibition of gene expression and proliferation of murine lymphoid cells in vitro.
Thompson EA
Cancer Res; 1989 Apr; 49(8 Suppl):2259s-2265s. PubMed ID: 2702666
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and molecular characterization of the glucocorticoid receptor of lymphosarcoma P1798 variants.
Lucas KL; Barbour KW; Housley PR; Thompson EA
Mol Endocrinol; 1988 Mar; 2(3):291-9. PubMed ID: 3398856
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition by glucocorticoids in RPMI 3460 melanoma cells.
Horn D; Buzard RL
Cancer Res; 1981 Aug; 41(8):3155-60. PubMed ID: 7248973
[TBL] [Abstract][Full Text] [Related]
6. Independence of the lethal actions of glucocorticoids on lymphoid cells from possible hormone effects on calcium uptake.
Nicholson ML; Young DA
J Supramol Struct; 1979; 10(2):165-74. PubMed ID: 582325
[TBL] [Abstract][Full Text] [Related]
7. Nonmutational alteration in glucocorticoid sensitivity of lymphosarcoma P1798.
Davis JM; Chan AK; Thompson EA
J Natl Cancer Inst; 1980 Jan; 64(1):55-62. PubMed ID: 6928047
[TBL] [Abstract][Full Text] [Related]
8. Neurotoxicity of soluble macrophage products in vitro--influence of dexamethasone.
Flavin MP; Ho LT; Coughlin K
Exp Neurol; 1997 Jun; 145(2 Pt 1):462-70. PubMed ID: 9217082
[TBL] [Abstract][Full Text] [Related]
9. Effect of glucocorticoid hormones in vitro on the structural integrity of nuclei in corticosteroid-sensitive and -resistant lines of lymphosarcoma P1798.
Nicholson ML; Young DA
Cancer Res; 1978 Nov; 38(11 Pt 1):3673-80. PubMed ID: 581273
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of Shionogi carcinoma 115 cells by glucocorticoid-induced autocrine heparin-binding growth factor(s) in serum-free medium.
Yamanishi H; Nonomura N; Tanaka A; Nishizawa Y; Terada N; Matsumoto K; Sato B
Cancer Res; 1991 Jun; 51(11):3006-10. PubMed ID: 2032238
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells.
Yano A; Fujii Y; Iwai A; Kageyama Y; Kihara K
Clin Cancer Res; 2006 May; 12(10):3003-9. PubMed ID: 16707595
[TBL] [Abstract][Full Text] [Related]
12. Kirsten sarcoma virus-immortalized mast cell lines. Reversible inhibition of growth by dexamethasone and evidence for the presence of an autocrine growth factor.
Tchekneva E; Serafin WE
J Immunol; 1994 Jun; 152(12):5912-21. PubMed ID: 8207216
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids enhance serum deprivation- but not calcium-induced cytotoxicity in rat C6 glioma cells.
Morita K; Wong DL
Cell Biol Int; 2000; 24(4):223-8. PubMed ID: 10816323
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids enhance the potency of Schwann cell mitogens.
Neuberger TJ; Kalimi O; Regelson W; Kalimi M; De Vries GH
J Neurosci Res; 1994 Jun; 38(3):300-13. PubMed ID: 7932865
[TBL] [Abstract][Full Text] [Related]
15. Regulation by glucocorticoids of cell differentiation and insulin-like growth factor binding protein production in cultured fetal rat nasal chondrocytes.
Nadra R; Menuelle P; Chevallier S; Berdal A
J Cell Biochem; 2003 Apr; 88(5):911-22. PubMed ID: 12616530
[TBL] [Abstract][Full Text] [Related]
16. Effect of rous sarcoma virus transformation of rat-1 fibroblasts upon their growth factor and anchorage requirements in serum-free medium.
Giguère L; Gospodarowicz D
Cancer Res; 1983 May; 43(5):2121-30. PubMed ID: 6299541
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of lymphosarcoma P1798 variants selected for resistance to the cytolytic effects of glucocorticoids in vivo and in culture.
Wood KM; Thompson EA
Mol Cell Endocrinol; 1984 Sep; 37(2):169-80. PubMed ID: 6092172
[TBL] [Abstract][Full Text] [Related]
19. The truncated glucocorticoid receptor in the P1798 mouse lymphosarcoma is associated with resistance to glucocorticoid lysis but not to other glucocorticoid-induced functions.
Ip MM; Shea WK; Sykes D; Young DA
Cancer Res; 1991 Jun; 51(11):2786-96. PubMed ID: 1674446
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death.
Uen YH; Ko PH; Yin PH; Liu TY; Chi CW; Lui WY
Int J Oncol; 2008 Dec; 33(6):1263-70. PubMed ID: 19020760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
